Loading content…
Affiliate-supportedIndependent editorialWe never sell medicationSee how
West · New Mexico
Local context for Wegovy, Ozempic, Mounjaro, and Zepbound in Albuquerque (560,000 residents, 920,000 metro). Centennial Care (NM Medicaid) covers T2D GLP-1s with prior auth; UNM Hospital anchors academic care.
Availability and prices vary by pharmacy and date. We do not maintain real-time per-pharmacy stock data. Confirm with pharmacies directly.
Wegovy
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for chronic weight management in adults and adolescents.
Wegovy in Albuquerque →
Ozempic
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for adults with type 2 diabetes.
Ozempic in Albuquerque →
Mounjaro
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for adults with type 2 diabetes.
Mounjaro in Albuquerque →
Zepbound
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for chronic weight management and obstructive sleep apnea.
Zepbound in Albuquerque →
Albuquerque is a west-region city with a population of 560,000 (920,000 in the broader metropolitan area). New Mexico expanded Medicaid under the Affordable Care Act, which means low-income adults can typically qualify for GLP-1 coverage for type 2 diabetes if the state Medicaid program lists the drug.
Statewide, notable health systems include University of New Mexico Health, Presbyterian Healthcare Services.
New Mexico's Medicaid program is Centennial Care. Coverage rules for GLP-1 medications vary by drug and indication; see our pricing by state map and payer-coverage guides for details.
Cities of similar size with comparable healthcare markets.